citrulline has been researched along with alx-0600 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abou-Assi, SG; Bernstein, CN; Buchman, AL; Fang, JC; Katz, S | 1 |
| Kerner, JA; Peterson, J | 1 |
| Forbes, A; Heinze, H; Iyer, K; Jeppesen, PB; Joelsson, B; Messing, B; O'keefe, SJ; Pertkiewicz, M; Seidner, DL | 1 |
| Acosta, A; Burton, D; Camilleri, M; Carlson, PJ; Edakkanambeth Varayil, J; Hurt, R; Iturrino, J; O'Neill, J; Zinsmeister, AR | 1 |
| Venick, RS | 1 |
| Gabe, SM; Jeppesen, PB; Lee, HM; Olivier, C; Seidner, DL | 1 |
2 review(s) available for citrulline and alx-0600
| Article | Year |
|---|---|
New advances in the management of children with intestinal failure.
Topics: Biomarkers; Child; Citrulline; Humans; Intestines; Lipids; Parenteral Nutrition; Peptides; Randomized Controlled Trials as Topic; Short Bowel Syndrome; Treatment Outcome | 2012 |
Predictors of Intestinal Adaptation in Children.
Topics: Adaptation, Physiological; Bacteremia; Biomarkers; Catheterization, Central Venous; Child; Citrulline; Enteral Nutrition; Gastrointestinal Agents; Humans; Liver Diseases; Parenteral Nutrition; Peptides; Prognosis; Short Bowel Syndrome | 2019 |
4 trial(s) available for citrulline and alx-0600
| Article | Year |
|---|---|
Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease.
Topics: Adolescent; Adult; Citrulline; Crohn Disease; Dose-Response Relationship, Drug; Female; Gastrointestinal Agents; Glucagon-Like Peptide 2; Humans; Male; Middle Aged; Peptides; Treatment Outcome; Young Adult | 2010 |
Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Citrulline; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Humans; Injections, Subcutaneous; Intestinal Absorption; Intestinal Diseases; Intestines; Male; Middle Aged; Parenteral Nutrition; Peptides; Prospective Studies; Short Bowel Syndrome; Treatment Outcome; Video Recording; Young Adult | 2012 |
Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition.
Topics: Adult; Aged; Citrulline; Cross-Over Studies; Double-Blind Method; Female; Gastric Emptying; Gastrointestinal Tract; Glucagon-Like Peptide 2; Humans; Intestinal Absorption; Lactulose; Male; Mannitol; Middle Aged; Parenteral Nutrition, Home; Peptides; Permeability; Pilot Projects; Recombinant Proteins; Short Bowel Syndrome; Treatment Outcome | 2016 |
Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
Topics: Adult; Citrulline; Colectomy; Colon; Drug Monitoring; Female; Gastrointestinal Agents; Humans; Intestine, Small; Linear Models; Male; Middle Aged; Parenteral Nutrition; Peptides; Postoperative Complications; Short Bowel Syndrome; Treatment Outcome | 2020 |